FDA Investigator Phillip D Waldron
Phillip D Waldron has conducted inspections on 93 sites in 1 countries as of 02 Oct 2007. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
93
Last Inspection Date:
02 Oct 2007
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Phillip D Waldron:
Alanna L Mussawwir Bias,
Amanda J White,
Amy E Jenkins Barnes,
Andrea A Branche,
Andrew B Bevill,
Anh M Lac,
Anya Dlockett Evans,
Bhanu M Kannan,
Bonnie L Fry,
Bonnie L Menzel,
Brian J Ryan,
Camille D Brown,
Charles D Brown,
Christin L Torres,
Christopher D Rush,
Christopher J Smith,
Connie L Hannon Rabel,
Corrine M Carter,
Cynthia A Harris, MD, RN,
Daniel J Lahar,
David M Beltran,
Elisa M Fleming,
Elizabeth A Waltrip,
Elmina E Akwo,
Elmina E Mboh,
Enspect User,
Frederic W French, III,
H Ljamilla Selby,
Habacuc V Barrera,
Hala L Selby,
Iris C Macinnes,
James H Robinson,
James R Fleckenstein,
Jennifer O Dowdy,
Jeremy W Rotton,
Joanne M Schlossin,
Jodi M Gatica,
Joel D Martinez,
John D Mays,
Karen C Daugherty,
Kelly J Pegg,
Leighton Kn Gai,
Leonard H Lavi,
Lisa A Doyle,
Lisa M Puttonen,
Maotang Zhou, PhD,
Marc R Dickens,
Margaret M Annes,
Monique S Frazier,
Patty P Kaewussdangkul,
Paula J Perry,
Pauline N Logan,
Philip M Steele, PhD,
Ralph H Vocque,
Rebecca C O'bryan,
Rebecca Co Bryan,
Rebecca Rodriguez,
Rhonda L Dash,
Robert T Harris,
Robert T Lorenz,
Ron Mabrysmelz,
Ronald C Mabry Smith,
Ronda Rloyd Jones,
Roy Baby,
Saijal P Naik,
Shawn E Larson,
Sherrie L Krolczyk,
Stephen D Brown,
Stephen L Beekman,
Tamera H Hunt,
Terrance L Thomas,
Theresa Kirkham (NMI),
Thomas J Arista,
Torrance J Slayton,
Travis M Beard
Phillip D Waldron's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more